These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8600463)

  • 41. N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models.
    Jansen B; Inoue SA; Wadl H; Eichler HG; Wolff K; Van Elsas A; Schrier PI; Pehamberger H
    Int J Cancer; 1996 Sep; 67(6):821-5. PubMed ID: 8824554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.
    Tokunaga T; Tsuchida T; Kijima H; Okamoto K; Oshika Y; Sawa N; Ohnishi Y; Yamazaki H; Miura S; Ueyama Y; Nakamura M
    Br J Cancer; 2000 Sep; 83(6):833-9. PubMed ID: 10952790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
    Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
    Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
    Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta.
    Shellman YG; Chapman JT; Fujita M; Norris DA; Maxwell IH
    J Invest Dermatol; 2000 Jun; 114(6):1200-4. PubMed ID: 10844567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes.
    Leavitt MC; Yu M; Yamada O; Kraus G; Looney D; Poeschla E; Wong-Staal F
    Hum Gene Ther; 1994 Sep; 5(9):1115-20. PubMed ID: 7833371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression.
    Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
    Cai DW; Mukhopadhyay T; Roth JA
    Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
    Dorai T; Kobayashi H; Holland JF; Ohnuma T
    Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
    Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
    Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes.
    Welch PJ; Marcusson EG; Li QX; Beger C; Krüger M; Zhou C; Leavitt M; Wong-Staal F; Barber JR
    Genomics; 2000 Jun; 66(3):274-83. PubMed ID: 10873382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of PLZF in melanoma progression.
    Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
    Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.
    Bai J; Gorantla S; Banda N; Cagnon L; Rossi J; Akkina R
    Mol Ther; 2000 Mar; 1(3):244-54. PubMed ID: 10933940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.